Table 2.

QoL in relation to method of treatment

A. HNF1A-MODY
	Present QOL		Impact of diabetes on QoL		Average weighted impact
HNF1A-MODY
On insulin (n = 30)	0.9	P = 0.02	−1.65	P < 0.0001	−2.33	P < 0.001
Other (n = 50)	1.3		−0.56		−1.03
HNF1A-MODY
On diet only (n = 14)	1.5	P = 0.03	−0.36	P = 0.01	−0.64	P < 0.01
On pharmacotherapy (n = 66)	1.08		−1.09		−1.71

B. GCK-MODY
	Present QOL		Impact of diabetes on QoL		Average weightened impact
GCK-MODY
Diabetic (n = 45)	1.08	P = 0.12	−0.54	P = 0.447	−0.9	P = 0.46
Prediabetic (n = 44)	1.36		−0.73		−1.0
GCK-MODY
On diet only (n = 69)	1.32	P = 0.06	−0.63	P = 0.65	−0.91	P = 0.33
On pharmacotherapy (n = 20)	0.95		−0.66		−1.0